User menu

Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia.

Bibliographic reference Orioli, Laura ; Sarti, K ; Van Den Neste, Eric ; Maiter, D. Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia.. In: Annals of Hematology, Vol. 96, no.4, p. 685-686 (2017)
Permanent URL http://hdl.handle.net/2078.1/183426
  1. Fain JS, Naeim F, Becker DP, Van Herle A, Yan-Go F, Petrus L, Vinters HV (1992) Chronic lymphocytic leukemia presenting as a pituitary mass lesion. Can J Neurol Sci 19:239–242
  2. Owen Carolyn, Assouline Sarit, Kuruvilla John, Uchida Cassandra, Bellingham Catherine, Sehn Laurie, Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective, 10.1016/j.clml.2015.07.649
  3. Lodish M. B., Stratakis C. A., Endocrine side effects of broad-acting kinase inhibitors, 10.1677/erc-10-0082
  4. Joshi M.N, Whitelaw B.C., Palomar M.T.P., Wu Y., Carroll P.V., Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review, 10.1111/cen.13063
  5. Bilgir O., Kebapcilar L., Bilgir F., Sarì I., Oner P., Karaca B., Alacacioglu I., Is there any relationship between imatinib mesylate medication and hypothalamic-pituitary-adrenal axis dysfunction? : Does imatinib cause glucocorticoid deficiency?, 10.1111/j.1742-1241.2008.01856.x